HENRY B. KIRBY, M.D.; BRUCE KENAMORE, M.D.; JAMES C. GUCKIAN, M.D., F.A.C.P.
Supported in part by grant 5T01AI00339, U.S. Public Health Service, Washington, D.C.
▸Requests for reprints should be adressed to James C. Guckian, M.D., Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Tex. 77550
KIRBY H., KENAMORE B., GUCKIAN J.; Pneumocystis carinii Pneumonia Treated with Pyrimethamine and Sulfadiazine. Ann Intern Med. 1971;75:505-509. doi: 10.7326/0003-4819-75-4-505
Download citation file:
Published: Ann Intern Med. 1971;75(4):505-509.
Pentamidine isethionate has been considered the only effective agent in the treatment of Pneumocystis carinii pneumonia. Its toxicity makes it less than the ideal drug. Pyrimethamine and sulfadiazine have been as effective as pentamidine in the treatment of P. carinii pneumonia in experimental animals. Results of prior reported treatment in human disease are reviewed. Three consecutive patients with biopsy-proved P. carinii pneumonia who were admitted to the medical service at the University of Texas Medical Branch Hospitals, Galveston, and treated with pyrimethamine and sulfadiazine are reported. Two patients were clinically cured and have had long-term follow-up. One patient showed clinical improvement with therapy but died of unknown causes shortly after completion of treatment; autopsy was not performed. The encouraging results obtained with the use of pyrimethamine and sulfadiazine indicate the need for further clinical trial with these readily available and relatively nontoxic antimicrobial agents.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Infectious Disease, Pulmonary/Critical Care, Pneumonia.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only